Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,136 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $244.85 | 12 | $0 (2024) |
| Amgen Inc. | $136.42 | 7 | $0 (2023) |
| Lilly USA, LLC | $131.16 | 7 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $125.00 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $94.37 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $52.50 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $45.83 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $41.25 | 2 | $0 (2023) |
| PFIZER INC. | $40.78 | 2 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $36.63 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $134.71 | 7 | Novo Nordisk Inc ($36.07) |
| 2023 | $359.65 | 17 | Novo Nordisk Inc ($60.83) |
| 2022 | $167.37 | 9 | Amgen Inc. ($42.22) |
| 2019 | $208.90 | 12 | Novo Nordisk Inc ($79.92) |
| 2018 | $140.70 | 7 | Novo Nordisk Inc ($43.73) |
| 2017 | $125.00 | 1 | Merck Sharp & Dohme Corporation ($125.00) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/17/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Diabetes | ||||||
| 11/09/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: INSOMNIA | ||||||
| 10/26/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Respiratory | ||||||
| 10/06/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Diabetes | ||||||
| 08/24/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Inflammation | ||||||
| 08/03/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Bone Health | ||||||
| 07/13/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Diabetes | ||||||
| 06/22/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/17/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Bone Health | ||||||
| 12/03/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
| 11/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/24/2019 | PFIZER INC. | CHANTIX (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/16/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Bone Health | ||||||
| 08/13/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/01/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Diabetes | ||||||
| 05/15/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Respiratory | ||||||
| 05/09/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Diabetes | ||||||
| 04/23/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Diabetes | ||||||
| 04/02/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/27/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Diabetes | ||||||
| 11/29/2018 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Neuroscience | ||||||
| 11/14/2018 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/03/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Diabetes | ||||||
| 09/19/2018 | SANOFI-AVENTIS U.S. LLC | LANTUS (Drug), TOUJEO, SOLIQUA | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: DIABETES | ||||||
| 08/21/2018 | PFIZER INC. | VIAGRA (Drug), CHANTIX, LYRICA | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,466 | 3,257 | $301,410 | $111,109 |
| 2022 | 33 | 2,547 | 3,275 | $301,731 | $106,408 |
| 2021 | 35 | 2,628 | 3,504 | $316,909 | $113,565 |
| 2020 | 37 | 2,773 | 3,561 | $318,028 | $101,714 |
All Medicare Procedures & Services
136 procedure records from CMS Medicare Utilization — Page 3 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 16 | $1,504 | $620.86 | 41.3% |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | Office | 2022 | 22 | 23 | $1,725 | $569.50 | 33.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 61 | 66 | $4,752 | $547.92 | 11.5% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2022 | 26 | 26 | $2,444 | $472.25 | 19.3% |
| 84460 | Liver enzyme (sgpt), level | Office | 2022 | 68 | 68 | $1,904 | $355.70 | 18.7% |
| 82043 | Urine microalbumin (protein) level | Office | 2022 | 62 | 62 | $1,860 | $353.38 | 19.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 62 | 62 | $1,674 | $317.01 | 18.9% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 23 | 35 | $1,610 | $312.10 | 19.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 20 | 20 | $1,540 | $297.40 | 19.3% |
| 82746 | Folic acid level, serum | Office | 2022 | 19 | 19 | $1,463 | $275.22 | 18.8% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 15 | 19 | $1,330 | $255.44 | 19.2% |
| 83550 | Iron binding capacity | Office | 2022 | 15 | 19 | $855.00 | $163.83 | 19.2% |
| 83540 | Iron level | Office | 2022 | 15 | 19 | $627.00 | $121.26 | 19.3% |
| 84550 | Uric acid level, blood | Office | 2022 | 13 | 14 | $322.00 | $62.18 | 19.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 187 | 325 | $74,425 | $30,610 | 41.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 244 | 382 | $59,974 | $23,208 | 38.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 155 | 155 | $35,495 | $22,106 | 62.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 98 | 100 | $10,600 | $6,513 | 61.4% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2021 | 36 | 38 | $11,400 | $2,850 | 25.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 192 | 205 | $14,145 | $2,745 | 19.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 13 | 13 | $4,420 | $2,345 | 53.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 187 | 207 | $11,385 | $2,186 | 19.2% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 130 | 223 | $11,150 | $2,165 | 19.4% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 17 | 17 | $6,137 | $2,117 | 34.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2021 | 169 | 248 | $10,912 | $2,098 | 19.2% |
About Dr. Robert Hurst, MD
Dr. Robert Hurst, MD is a Internal Medicine healthcare provider based in Bloomingdale, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972579142.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Hurst, MD has received a total of $1,136 in payments from pharmaceutical and medical device companies, with $134.71 received in 2024. These payments were reported across 53 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,136).
As a Medicare-enrolled provider, Hurst has provided services to 10,414 Medicare beneficiaries, totaling 13,597 services with total Medicare billing of $432,796. Data is available for 4 years (2020–2023), covering 136 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bloomingdale, IL
- Active Since 02/27/2006
- Last Updated 08/08/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1972579142
Products in Payments
- Ozempic (Drug) $168.67
- BRIDION (Drug) $125.00
- EVENITY (Biological) $97.43
- JARDIANCE (Drug) $83.76
- FARXIGA (Drug) $66.49
- MOUNJARO (Drug) $61.32
- REXULTI (Drug) $52.50
- Rybelsus (Drug) $44.01
- AREXVY (Drug) $41.25
- XARELTO (Drug) $36.63
- Kerendia (Drug) $30.67
- QUVIVIQ (Drug) $28.73
- Cologuard Collection Kit (Device) $24.96
- LANTUS (Drug) $21.94
- Repatha (Biological) $21.76
- VIAGRA (Drug) $21.73
- FREESTYLE LIBRE 3 (Device) $19.93
- CHANTIX (Drug) $19.05
- TRULICITY (Drug) $18.80
- Otezla (Drug) $17.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bloomingdale
Dr. Aziz Ahmed, M.d, M.D
Internal Medicine — Payments: $12,894
Vanja Cuk, Md, MD
Internal Medicine — Payments: $8,808
Dr. Sanjay Patel, M.d, M.D
Internal Medicine — Payments: $5,443
Dr. Mahrukh Subhani, M.d, M.D
Internal Medicine — Payments: $2,723
Sonal Patel, Do, DO
Internal Medicine — Payments: $753.69
Wahaj Ahmed, M.d, M.D
Internal Medicine — Payments: $670.83